Sangamo Therapeutics Inc (NASDAQ:SGMO)
| 3.51 Delayed Data As of Feb 03 |  -0.16 / -4.36%Today’s Change | 2.72 Today|||52-Week Range 6.42 | +11.78% Year-to-Date |
Institutional investors hold a majority ownership of SGMO through the 60.31% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2019, these large investors purchased a net $7.6 million shares.
| Mutual fund holders | 37.73% |
| Other institutional | 22.58% |
| Individual stakeholders | 19.19% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 11/30/2022 | NORDEA INVESTMENT MANAGEMENT AB Bought 39.2 Thousand shares of Sangamo Therapeutics Inc |
| 1/05/2023 | IRISH LIFE INVESTMENT MANAGERS L... Bought 7.8 Thousand shares of Sangamo Therapeutics Inc |
| 12/31/2022 | LINDBROOK CAPITAL LLC Bought 3.6 Thousand shares of Sangamo Therapeutics Inc |
Top 10 Owners of Sangamo Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Wasatch Advisors, Inc. | 8.01% | 13,122,116 | 41,203,444 | +729,797 | +5.89% |
| The Vanguard Group, Inc. | 7.65% | 12,532,387 | 39,351,695 | +1,212,609 | +10.71% |
| BlackRock Fund Advisors | 6.38% | 10,458,043 | 32,838,255 | +929,040 | +9.75% |
| SSgA Funds Management, Inc. | 4.25% | 6,968,276 | 21,880,387 | -771,195 | -9.96% |
| Credit Suisse Asset Management (S... | 2.31% | 3,789,332 | 11,898,502 | +9,110 | +0.24% |
| Dimensional Fund Advisors LP | 1.87% | 3,070,841 | 9,642,441 | -12,786 | -0.41% |
| Rokos Capital Management LLP | 1.85% | 3,026,210 | 9,502,299 | 0 | 0.00% |
| Geode Capital Management LLC | 1.45% | 2,382,435 | 7,480,846 | +213,422 | +9.84% |
| Avidity Partners Management LP | 1.44% | 2,360,800 | 7,412,912 | +2,360,800 | -- |
| Teachers Advisors LLC | 1.19% | 1,954,906 | 6,138,405 | +1,011,847 | +107.29% |
Top 10 Mutual Funds Holding Sangamo Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | 4.23% | 6,934,157 | 21,773,253 | +28,032 | +0.41% |
| Wasatch Ultra Growth Fund | 3.03% | 4,959,973 | 15,574,315 | +679,916 | +15.89% |
| Vanguard Total Stock Market Index... | 2.54% | 4,164,900 | 13,077,786 | 0 | 0.00% |
| CS Invt. Fds. 2 - (Lux) Digital H... | 2.26% | 3,700,000 | 11,618,000 | 0 | 0.00% |
| Wasatch Small Cap Growth Fund | 1.85% | 3,037,197 | 9,536,799 | +54,595 | +1.83% |
| iShares Russell 2000 ETF | 1.79% | 2,936,538 | 9,220,729 | -30,622 | -1.03% |
| Vanguard Extended Market Index Fu... | 1.13% | 1,844,692 | 5,792,333 | +20,701 | +1.13% |
| Vanguard Small Cap Index Fund | 1.10% | 1,794,712 | 5,635,396 | +70,869 | +4.11% |
| LO Selection - NextGen BioTech | 0.86% | 1,409,736 | 4,426,571 | +561,307 | +66.16% |
| JPMorgan Funds - Thematics - Gene... | 0.85% | 1,400,072 | 4,396,226 | -100,883 | -6.72% |